{
    "clinical_study": {
        "@rank": "102778", 
        "brief_summary": {
            "textblock": "Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry\n      eye."
        }, 
        "brief_title": "Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye", 
        "completion_date": {
            "#text": "March 2003", 
            "@type": "Actual"
        }, 
        "condition": "Keratoconjunctivitis Sicca", 
        "condition_browse": {
            "mesh_term": [
                "Keratoconjunctivitis Sicca", 
                "Dry Eye Syndromes", 
                "Keratoconjunctivitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  have Non-Sjogren's associated dry eye disease with symptoms lasting greater than 6\n             months\n\n          -  had intermittent or regular artificial tear use within past 3 months\n\n        Exclusion Criteria:\n\n          -  had LASIK surgery\n\n          -  had punctal occlusion or cauterization within last 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "222", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 18, 2002", 
        "id_info": {
            "nct_id": "NCT00037661", 
            "org_study_id": "03-108"
        }, 
        "intervention": {
            "intervention_name": "INS365 Ophthalmic Solution", 
            "intervention_type": "Drug"
        }, 
        "keyword": "dry eye", 
        "lastchanged_date": "October 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Andover", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "01810"
                }, 
                "name": "Ophthalmic Research Associates, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2003", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00037661"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Merck Sharp & Dohme Corp.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2002", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }, 
    "geocoordinates": {
        "Ophthalmic Research Associates, Inc.": "42.658 -71.137"
    }
}